What is included in the long-term monitoring of patients with mucormycosis (zygomycosis)?

Updated: Jul 06, 2021
  • Author: Avnish Sandhu, DO; Chief Editor: Pranatharthi Haran Chandrasekar, MBBS, MD  more...
  • Print

There is no definitive guidance on duration of therapy, and weeks to months of therapy usually are given; ECMM strongly suggests treatment until immunosuppression is resolved, diabetes is effectively controlled, and complete response is seen on imaging. [39]

Successful courses of amphotericin B typically last 4-6 weeks. Primary or salvage isavuconazole therapy may be continued for several months given its higher tolerability compared with amphotericin. Repeated surgical debridement of necrotic tissue identified by follow-up head computed tomography (CT) scan or magnetic resonance imaging (MRI) is often indicated.

Ongoing clinical surveillance and diagnostic imaging are required to ensure complete resolution of mucormycosis and to detect relapse.

Educate patients about the signs of disease, such as facial swelling and black nasal discharge, and instruct patients to present promptly for evaluation if these signs occur.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!